The deadlines and procedures are set out in the evaluation result letter. For more information on complaints about proposal rejection: https://webgate.ec.europa.eu/funding-tenders-opportunities/display/OM/Complaints+about+proposal+rejection.

There are 3 possible links: [Same group] if the legal entity is under the same direct or indirect control as another legal entity; [Controls] if a legal entity directly or indirectly controls another legal entity; or [Is controlled by] if a legal entity is directly or indirectly controlled by another legal entity.

It depends because some proposals can be very similar, for instance in the case of resubmission; and others are not quite similar, but they are still considered similar, for instance in the case of continuation. Even if the applicant mentions that a similar proposal has been submitted, this will be checked very carefully by REA. If after checking REA sees it is not the case, they will not consider it to be similar.

Formally if there is not an accreditation, then it would not be counted as a joint, double or multiple degrees.The policy objective behind the DNs is mutual recognition and capacity building and to have the same recognition of the doctoral degrees from the different universities and different countries at the same level. It is difficult but just providing mentorship would not qualify completely.

The answer is in between. It is not necessary to have already at proposal stage the programmes officially recognised and the joint or multiple doctorates in place but for joint doctorates, there is a commitment of several doctoral degree awarding institutions, who have this mutually official recognition of the different curricula. So it is necessary that at the end of the projects, all the fellows involved in the joint doctorates, have a joint, multiple or double degree. It’s a very lengthy process, usually underestimated by applicants. There are strong rules about curriculum design in different universities from different countries.

In the MSCA-DN template ‘other diversity aspects’ refers to biological characteristics and social/ cultural factors respectively, aspects that are not fully under ‘gender’ but are considered as ‘other diversity aspects’. In MSCA the scope is a little bit wider than in the other Horizon Europe parts.

The deadlines and procedures are set out in the evaluation result letter. For more information on complaints about proposal rejection: https://webgate.ec.europa.eu/funding-tenders-opportunities/display/OM/Complaints+about+proposal+rejection.

Yes. Such an additional contract in the US can be for example to ensure equivalent benefits and social security coverage. Below is an example provided by the European Commission:

Example: A BE university recruits the fellow for the total duration of the action (i.e. provides the main employment contract under the action) and sends him/her to a US university. Continuing the Belgian social security during the stay in the US could be too expensive, so that the beneficiary asks the US partner organisation to conclude an additional employment contract, in order to insure the researcher in the US.

Yes, there has to be a transfer of money from the institution of the return phase to the partner hosting the outgoing phase. Partnership agreement should be signed and should define such a transfer. Country correction coefficient (CCC) of the partner hosting the outgoing phase will be applied. The transfer can include not only living allowance but also mobility and family contribution or transfer of institutional contribution.

No. The researcher should be recruited by the institution of the return phase (the European beneficiary) under an employment contract that covers the entire duration of the grant agreement, including the outgoing phase (36 months total). It is then possible for the partner hosting the outgoing phase (the Third country organisation) to sign an additional employment contract with the researcher for just those 24 months of the outgoing phase, but the main contract will be with the beneficiary in Europe. In the practice different scenarios can occur, e.g. for the time of the outgoing phase (i.e. 24 months) the institution of the return phase will provide unpaid leave to the researcher – i.e. the researcher remains employee of the institution of the return phase but receives no salary from this institution.

It may be possible if the challenges are insurmountable.

Firstly, the fellow and the beneficiary should of course try to solve the issues and also document the process.

But if that fails, they should contact their Project Officer. Best practice would be to already be able to suggest an alternative that would ensure that the project could be implemented according to/or as close as possible to what has been evaluated.

The return phase always lasts 12 months, there are no exceptions. Starting at the European institution counts as outgoing. This means that if the outgoing phase is 24 months, only 21 months will be left after the secondment at the European return host.

Timesheets and declarations are not requested in MSCA projects (contrary to other Horizon Europe actions based on actual costs). To prove that the researcher worked on their MSCA project, it is sufficient to present a contract with the host institution together with additional documents proving the fellow’s dedication to the project, if needed.

Moreover, declarations are not allowed by the auditors. REA has confirmed that the declaration on exclusive work is not applicable for audits carried out in MSCA ITN, IF and COFUND actions to determine time spent working on the action. It is expected this will continue in Horizon Europe.

As outlined in the H2020 Indicative Audit Programme, such evidence may include lab books, attendance lists, conference abstracts, library records, travel expenses, timesheets, reports to supervisor, meeting minutes, e-mail exchanges, etc. and other open sources (e.g. the internet) to see if the researcher worked on activities other than their  project. The auditors will also look at the researcher’s employment contract or corresponding agreement to see if it complies with Article 32 of the H2020 Annotated Model Grant Agreement, including but not limited to the obligation that the researcher works exclusively for the action.

Fellows need documentation in the form of a contract that shows the 50% commitment or something similar since MSCA does not typically operate with timesheets.

Organisations can only encode secondments that are eligible for EC funding. So organisations could encode the secondments going to the UK, but not those from the UK to a beneficiary. It is the dates included in the mobility declarations (previously researchers’ declarations) which are used for financial reporting.  

The researcher is eligible to participate, the change of status does not affect their eligibility.

The UK partners will be funded with the UKRI Horizon Europe Guarantee, in line with the original budget line. They will no longer be able to be included as a beneficiary but will need to become Associated Partners (APs).  Secondments to UK APs from Member States (MS) and/ or Associated Countries (AC) will be funded by the EC as originally foreseen in the proposal. Secondments from UK APs to MS/ AC/ other APs will be funded via UKRI, in line with the budget line and secondment plan in the proposal. Secondments from another AP to the UK will also be funded via UKRI.